NightHawk Biosciences (NHWK) currently reports a inventory of $200B as of September 2025. That compares with $180B in the prior-year period — up 16.2% year over year. Use the charts on this page to explore NightHawk Biosciences's inventory history and peer comparisons.

NightHawk Biosciences's inventory increased from $180B to $200B — a 16.2% year-over-year increase (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NightHawk Biosciences reported $200B in inventory as of September 2025. That compares with $180B in the prior-year period — up 16.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $200B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NightHawk Biosciences, and consider following NHWK for alerts when major investors trade the stock.

NightHawk Biosciences is classified in the Healthcare sector. On inventory, it currently shows $200B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NHWK with unrelated industries.